Page last updated: 2024-10-24

carteolol and Mitral Valve Insufficiency

carteolol has been researched along with Mitral Valve Insufficiency in 2 studies

Carteolol: A beta-adrenergic antagonist used as an anti-arrhythmia agent, an anti-angina agent, an antihypertensive agent, and an antiglaucoma agent.

Mitral Valve Insufficiency: Backflow of blood from the LEFT VENTRICLE into the LEFT ATRIUM due to imperfect closure of the MITRAL VALVE. This can lead to mitral valve regurgitation.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shioto, T1
Takenaka, K1
Sakamoto, T1
Amano, K1
Suzuki, J1
Amano, W1
Takahashi, H1
Sugimoto, T1
Saito, K1
Fukuda, Y1
Kawano, T1
Uchida, T1
Tominaga, T1
Fukuda, N1
Oki, T1
Mori, H1

Other Studies

2 other studies available for carteolol and Mitral Valve Insufficiency

ArticleYear
[Antiarrhythmic action of beta-blocking agent in patients with mitral valve prolapse having premature ventricular contractions].
    Journal of cardiology. Supplement, 1989, Volume: 21

    Topics: Adolescent; Adult; Anti-Arrhythmia Agents; Blood Pressure; Cardiac Complexes, Premature; Carteolol;

1989
[Diurnal variation of the QT intervals in idiopathic mitral valve prolapse].
    Journal of cardiology. Supplement, 1988, Volume: 18

    Topics: Adolescent; Adult; Autonomic Nervous System; Carteolol; Circadian Rhythm; Electrocardiography; Exerc

1988